Literature DB >> 21931119

Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients.

Leonardo Potenza1, Daniela Vallerini, Patrizia Barozzi, Giovanni Riva, Fabio Forghieri, Eleonora Zanetti, Chiara Quadrelli, Anna Candoni, Johan Maertens, Giulio Rossi, Monica Morselli, Mauro Codeluppi, Ambra Paolini, Monica Maccaferri, Cinzia Del Giovane, Roberto D'Amico, Fabio Rumpianesi, Monica Pecorari, Francesca Cavalleri, Roberto Marasca, Franco Narni, Mario Luppi.   

Abstract

Mucorales-specific T cells were investigated in 28 hematologic patients during the course of their treatment. Three developed proven invasive mucormycosis (IM), 17 had infections of known origin but other than IM, and 8 never had fever during the period of observation. Mucorales-specific T cells could be detected only in patients with IM, both at diagnosis and throughout the entire course of the IM, but neither before nor for long after resolution of the infection. Such T cells predominantly produced IL-4, IFN-γ, IL-10, and to a lesser extent IL-17 and belonged to either CD4(+) or CD8(+) subsets. The specific T cells that produced IFN-γ were able to directly induce damage to Mucorales hyphae. None of the 25 patients without IM had Mucorales-specific T cells. Specific T cells contribute to human immune responses against fungi of the order Mucorales and could be evaluated as a surrogate diagnostic marker of IM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931119     DOI: 10.1182/blood-2011-07-366526

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

Review 1.  Update on mucormycosis pathogenesis.

Authors:  Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

2.  In Vivo and In Vitro Impairments in T Helper Cell and Neutrophil Responses against Mucor irregularis in Card9 Knockout Mice.

Authors:  Lingyue Sun; Shuzhen Zhang; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

3.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

Review 4.  Challenges in the diagnosis and treatment of mucormycosis.

Authors:  A Skiada; C Lass-Floerl; N Klimko; A Ibrahim; E Roilides; G Petrikkos
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

5.  Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.

Authors:  Russell E Lewis; Sarah P Georgiadou; Fotis Sampsonas; George Chamilos; Dimitrios P Kontoyiannis
Journal:  Mycoses       Date:  2013-06-12       Impact factor: 4.377

6.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

7.  Emerging invasive fungal diseases in transplantation.

Authors:  Perrine Parize; Blandine Rammaert; Olivier Lortholary
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 8.  Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections.

Authors:  Alexander Scheffold; Carsten Schwarz; Petra Bacher
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

Review 9.  The mucormycete-host interface.

Authors:  Ashraf S Ibrahim; Kerstin Voelz
Journal:  Curr Opin Microbiol       Date:  2017-11-04       Impact factor: 7.934

10.  Case Report: Rhizopus arrhizus Rhino-Orbital-Cerebral Mycosis and Lethal Midline Granuloma: Another Fungal Etiological Agent.

Authors:  Dong Ming Li; Li De Lun; Jie Ge; Gong Jie Zhang; Xin Lun Li; G Sybren de Hoog
Journal:  Front Med (Lausanne)       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.